Crystal form of Dabrafenib mesylate and preparation method thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9884856
SERIAL NO

15247086

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention involves novel crystal forms of Dabrafenib mesylate and preparation method thereof, wherein the novel crystal forms are more stable in water or an aqueous system, and have greater solubility and dissolution rate in water, thus having better stability and bioavailability compared with the existing crystal forms.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HANGZHOU SOLIPHARMA CO LTDSUITE 2B05 BUILDING 1 NO 452 6TH AVE HANGZHOU ECONOMIC AND TECHNOLOGY DEVELOPMENT AREA HANGZHOU ZHEJIANG 310018

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lao, Haiping Hangzhou, CN 4 5
Sheng, Xiaohong Hangzhou, CN 34 32
Sheng, Xiaoxia Hangzhou, CN 40 132

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 6, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 6, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00